Oncologists currently find it difficult to select optimal treatment and management strategies for patients with multiple myeloma. Inadequate diagnostics, sub-optimal treatment and imprecise disease monitoring shorten the lives of multiple myeloma patients. We are developing a data-driven algorithm that yields effective personalized treatment strategies
Company’s Keywords:
immunooncology, medical device, multiple myeloma, diagnostics, next generation sequencing
<0
<
<
<2020